Core Viewpoint - The company, Yuan Da Pharmaceutical (00512.HK), announced the acquisition of two companies for a total consideration of RMB 316 million, which will enhance its portfolio in the amino acid and thiol product sectors [1] Group 1: Acquisition Details - The acquisition involves Hubei Yuan Da, a subsidiary in which the company holds a 99.84% indirect non-wholly owned interest, as the buyer [1] - The sellers are China Yuan Da Group Co., Ltd. and Wuhan Jiu Xiang Biotechnology Partnership (Limited Partnership) [1] - The target companies include Hebei Yuan Da Jiu Fu Biotechnology Co., Ltd., established in 2004, focusing on the production and sales of amino acid products, and Baoding Jia He Fine Chemical Co., Ltd., established in 2005, specializing in the processing, manufacturing, and sales of thiol products [1]
远大医药(00512.HK)附属拟3.16亿元收购河北远大九孚与保定加合全部股权